Advertisement

10 Results

for author "Ahmad S. Halwani"

Type a term to search within all articles in this journal: e.g., stem cell
Citation
Citation-specific search information
e.g., 2009
e.g., 20
e.g., 3
e.g., 29
e.g., 10.9999/123XYZ456
Authors, Keywords
Search for specific authors and/or words and phrases.
e.g., Smith, JS
e.g., Smith, JS
Type any phrase that appears in the article title
Type any phrase that appears within article title or abstract
Type any phrase that appears within article body, title or abstract
e.g., Smith, JS
Book publisher name
Limit Results
Limit search results by date
Date of Publication
e.g., 2017-01-19
e.g., 2017-01-19
Format Results
  • Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) after Treatment with Nivolumab for Relapsed/Refractory Hodgkin Lymphoma
    Philippe Armand, Pier Luigi Zinzani, Graham P. Collins, Jonathon B. Cohen, Ahmad S. Halwani, Carmelo Carlo-Stella, Michael M. Millenson, Mariano Provencio, Eva Domingo Domenech, Lisa Giulino Roth, Luca Castagna, Kazunobu Kato, Mihaela Popa McKiver, Anne Sumbul, Lili Zhu, Armando Santoro
    ...B. Cohen , MD 4 , Ahmad S. Halwani , MD 5 , Carmelo Carlo-Stella , MD 6 , Michael M. Millenson , MD 7 , Mariano Provencio , MD PhD * , 8 , Eva Domingo Domenech , MD * , 9 , Lisa Giulino Roth , MD 10 , Luca ~~~
  • Preliminary Results of a Phase 1 Trial Evaluating MRG-106, a Synthetic microRNA Antagonist (LNA antimiR) of microRNA-155, in Patients with CTCL
    Christiane Querfeld, Theresa Pacheco, Francine M. Foss, Ahmad S. Halwani, Pierluigi Porcu, Anita G Seto, Judy Ruckman, Michele L Landry, Aimee L Jackson, Linda A Pestano, Brent A Dickinson, Mark Sanseverino, David M Rodman, Gilad Gordon, William Marshall
    ...Judy Ruckman BA Dickinson M.L. Landry Foss A Seto A.L. Jackson Christiane LindaA Pestano Querfeld Michele AhmadS Halwani Querfeld Christiane Foss, F Gordon, G Jackson, A Linda A, Pestano Anita G Seto W Marshall Halwani, AS DM Rodman Marshall, William Christiane Querfeld Judy, Ruckman Michele Landry ~~~
  • Safety and Efficacy of Allogeneic Hematopoetic Stem Cell Transplant (HSCT) after Treatment with Programmed Cell Death 1 (PD-1) Inhibitors
    Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani, Carmelo Carlo-Stella, Stephen M Ansell, Ahmad S. Halwani, Miguel-Angel Perales, Vincent T. Ho, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer, Philippe Armand
    ..., H AhmadS Halwani JH Antin Antin C Carlo-Stella Soiffer, R.J Vincent Robert J RJ Soiffer Merryman, Reid W Soiffer Armand Philippe Halwani, AS Pier Zinzani R.W. Merryman Ansell, Stephen M Zinzani, P Zinzani Pier Luigi R Soiffer Ahmad S, Halwani Haesook T Miguel-Angel Robert J, Soiffer Ansell, S.M HT ~~~
  • Safety and Efficacy of Allogeneic Hematopoietic Stem Cell Transplant After PD-1 Blockade in Relapsed/Refractory Lymphoma
    Reid W. Merryman, Haesook T. Kim, Pier Luigi Zinzani, Carmelo Carlo-Stella, Stephen M. Ansell, Miguel-Angel Perales, Abraham Avigdor, Ahmad S. Halwani, Roch Houot, Tony Marchand, Nathalie Dhedin, Willy Lescaut, Anne Thiebaut-Bertrand, Sylvie François, Aspasia Stamatoullas-Bastard, Pierre-Simon Rohrlich, Hélène Labussière Wallet, Luca Castagna, Armando Santoro, Veronika Bachanova, Scott C. Bresler, Amitabh Srivastava, Harim Kim, Emily Pesek, Marie Chammas, Carol Reynolds, Vincent T. Ho, Joseph H. Antin, Jerome Ritz, Robert J. Soiffer, Philippe Armand
    ...-Angel Perales 6 , Abraham Avigdor 7 , Ahmad S. Halwani 8 , Roch Houot 9 , Tony Marchand 10 , Nathalie Dhedin 11 , Willy Lescaut 12 , Anne Thiebaut-Bertrand 13 , Sylvie François 14 , Aspasia Stamatoullas-Bastard 15 ~~~
  • Venetoclax (VEN) Monotherapy for Patients with Chronic Lymphocytic Leukemia (CLL) Who Relapsed after or Were Refractory to Ibrutinib or Idelalisib
    Jeffrey Jones, Michael Y. Choi, Anthony R. Mato, Richard R. Furman, Matthew S. Davids, Leonard T. Heffner, Bruce D. Cheson, Nicole Lamanna, Paul M. Barr, Herbert Eradat, Ahmad Halwani, Brenda Chyla, Ming Zhu, Maria Verdugo, Rod A. Humerickhouse, Jalaja Potluri, William G. Wierda, Steven E. Coutre
    ..., Matthew S. Davids 5 , Leonard T. Heffner , MD 6 , Bruce D. Cheson 7 , Nicole Lamanna , MD 8 , Paul M. Barr 9 , Herbert Eradat 10 , Ahmad Halwani 11 , Brenda Chyla * , 12 , Ming Zhu * , 12 ~~~
  • Results of an Ongoing Phase 2 Study of Brentuximab Vedotin with Rchp As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL)
    Lihua E. Budde, Ahmad Halwani, Christopher A. Yasenchak, Charles Michael Farber, John M Burke, Luis E. Fayad, Beata Holkova, Mark Knapp, Kathryn S. Kolibaba, Ranjana H Advani, Stephen M Ansell, Dipti Patel-Donnelly, Habte A. Yimer, Scott E. Smith, Moshe Yair Levy, Mahesh Seetharam, David Belada, Donald Brooks, Edwin C. Kingsley, Leonard M. Klein, Nina Wagner-Johnston, Katherine Ruffner, Nancy L Bartlett
    ...Results of an Ongoing Phase 2 Study of Brentuximab Vedotin with Rchp As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL) Lihua E. Budde , MD PhD 1 , Ahmad Halwani 2 , Christopher A. Yasenchak 3 ~~~
  • Brentuximab Vedotin with RCHOP As Frontline Therapy in Patients with High-Intermediate/High-Risk Diffuse Large B Cell Lymphoma (DLBCL): Results from an Ongoing Phase 2 Study
    Christopher A. Yasenchak, Ahmad Halwani, Ranjana Advani, Stephen Ansell, Lihua Elizabeth Budde, John M. Burke, Charles M. Farber, Beata Holkova, Luis E. Fayad, Kathryn S. Kolibaba, Mark Knapp, Martha Li, Thomas J. Manley, Dipti Patel-Donnelly, Mahesh Seetharam, Habte A. Yimer, Nancy L Bartlett
    ...Farber KS Kolibaba John K Kolibaba Knapp Mark LE Budde Farber, C.M Advani, R ChristopherA Yasenchak Burke, J Fayad, L Farber Charles M. Li, M Habte A, Yimer Lihua Ahmad Halwani Mahesh CharlesM Farber K.S. Kolibaba NL Bartlett Yimer, H Patel-Donnelly, D Ansell, S Kolibaba, Kathryn S Fayad Luis E. Habte ~~~
  • Brentuximab Vedotin in Combination with RCHOP As Front-Line Therapy in Patients with DLBCL: Interim Results from a Phase 2 Study
    Christopher A. Yasenchak, Charles M. Farber, Lihua Elizabeth Budde, Stephen M. Ansell, Ranjana Advani, Beata Holkova, Ahmad Halwani, Mark Knapp, Luis Fayad, Kathryn S. Kolibaba, Dipti Patel-Donnelly, Mahesh Seetharam, Thomas J. Manley, Nancy L. Bartlett
    ....A Patel-Donnelly, Dipti Fayad Kolibaba, K.S Ranjana Ranjana, Advani Fayad Luis Charles Farber L.E. Budde CM Farber C Yasenchak Ansell, Stephen M Yasenchak, Christopher A Ahmad, Halwani Kathryn Farber, CM Ansell, S.M Lihua Elizabeth Budde Luis Luis Fayad Mark, Knapp ThomasJ Manley L Budde TJ Manley Advani ~~~
  • Nivolumab in Patients with Relapsed or Refractory Hodgkin Lymphoma - Preliminary Safety, Efficacy and Biomarker Results of a Phase I Study
    Philippe Armand, Stephen M. Ansell, Alexander M. Lesokhin, Ahmad Halwani, Michael M. Millenson, Stephen J. Schuster, John Timmerman, Ivan Borrello, Martin Gutierrez, Emma C. Scott, Deepika Cattry, Bjoern Chapuy, Azra H. Ligon, Scott J. Rodig, Lili Zhu, Joseph F. Grosso, Su Young Kim, Margaret A. Shipp
    ...Ahmad Halwani S Kim Grosso Joseph F. SY Kim Ivan Alexander MA Shipp Su Kim Gutierrez Ansell, S Gutierrez, M A Ligon Azra H EmmaC Scott M.M. Millenson Emma C, Scott Schuster, S.J Scott J, Rodig JF Grosso Borrello, Ivan Emma C Scott Grosso, J.F Halwani Ahmad JosephF Grosso Scott Cattry Deepika Timmerman ~~~
  • Preliminary Results of a Phase I Study of Nivolumab (BMS-936558) in Patients with Relapsed or Refractory Lymphoid Malignancies
    Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand, Emma C. Scott, Ahmad Halwani, Martin Gutierrez, Michael M. Millenson, Adam D. Cohen, Stephen J. Schuster, Daniel Lebovic, Madhav V. Dhodapkar, David Avigan, Bjoern Chapuy, Azra H. Ligon, Scott J. Rodig, Deepika Cattry, Lili Zhu, Joseph F. Grosso, Su Young Kim, Margaret A. Shipp, Ivan Borrello, John Timmerman
    ...Martin Gutierrez John Philippe Shipp, M Lili Zhu Lili, Zhu Joseph Grosso Chapuy Deepika Cattry M.V. Dhodapkar Kim AD Cohen Azra H Ligon Scott, E.C Philippe Armand Adam Daniel Lebovic Ahmad Halwani Cohen, A S Kim Grosso Joseph F. MadhavV Dhodapkar SY Kim Ivan Alexander MA Shipp Su Kim Gutierrez, M ~~~